Alimta and Abdominal pain - a phase IV clinical study of FDA data
Summary:
Abdominal pain is found among people who take Alimta, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Alimta and have Abdominal pain. It is created by eHealthMe based on reports of 7,644 people who have side effects when taking Alimta from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
7,644 people reported to have side effects when taking Alimta.
Among them, 145 people (1.9%) have Abdominal pain.
What is Alimta?
Alimta has active ingredients of pemetrexed disodium. eHealthMe is studying from 7,700 Alimta users for its effectiveness, alternative drugs and more.
What is Abdominal pain?
Abdominal pain is found to be associated with 4,732 drugs and 4,931 conditions by eHealthMe.
Number of Alimta and Abdominal pain reports submitted per year:

Time on Alimta when people have Abdominal pain *:
Gender of people who have Abdominal pain when taking Alimta*:
Age of people who have Abdominal pain when taking Alimta *:
Common drugs people take besides Alimta *:
Common side effects people have besides Abdominal pain *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Alimta and have Abdominal pain?
Check whether Abdominal pain is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
Related studies
How severe was Abdominal pain and when was it recovered:
Expand to all the drugs that have ingredients of pemetrexed disodium:
Alternative drugs to, pros and cons of Alimta:
- Alimta (7,700 reports)
Common Alimta side effects:
- Thrombocytopenia (decrease of platelets in blood): 711 reports
- Death: 690 reports
- Rashes (redness): 456 reports
- Breathing difficulty: 424 reports
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 418 reports
Browse all side effects of Alimta:
a b c d e f g h i j k l m n o p q r s t u v w x y zAbdominal pain treatments and more:
- Abdominal pain (246,157 reports)
COVID vaccines that are related to Abdominal pain:
- Abdominal pain in Moderna COVID Vaccine
- Abdominal pain in Pfizer BioNTech Covid Vaccine
- Abdominal pain in Johnson and Johnson Covid Vaccine
Common drugs associated with Abdominal pain:
- Humira: 15,786 reports
- Prednisone: 14,882 reports
- Methotrexate: 9,506 reports
- Aspirin: 9,343 reports
- Omeprazole: 8,436 reports
- Metformin: 8,314 reports
- Mirena: 7,922 reports
- Pantoprazole: 6,761 reports
- Synthroid: 6,079 reports
- Tylenol: 6,027 reports
All the drugs that are associated with Abdominal pain:
- Abdominal pain (4,732 drugs)
Common conditions associated with Abdominal pain:
- Crohn's disease: 18,846 reports
- Birth control: 11,549 reports
- High blood pressure: 10,348 reports
- Rheumatoid arthritis: 9,807 reports
- Pain: 9,036 reports
- Ulcerative colitis: 6,312 reports
All the conditions that are associated with Abdominal pain:
- Abdominal pain (4,931 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on pemetrexed disodium (the active ingredients of Alimta) and Alimta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Detrol and Nosebleed - 2 seconds ago
- Ramipril and Scurvy - 2 seconds ago
- Aranesp and Periodontitis - 3 seconds ago
- Mirena and Actemra drug interaction - 3 seconds ago
- Xifaxan and Multiple Fractures - 8 seconds ago
- Viread and Gilbert'S Syndrome - 9 seconds ago
- Isradipine and Blindness - 11 seconds ago
- Mesalamine and Movement - Uncontrolled Or Slow - 19 seconds ago
- Norvasc and Eyelid Function Disorder - 23 seconds ago
- Ceftriaxone and Splenic Haematoma - 24 seconds ago